Suchergebnisse - "Li, Yong"

PubPharm (5)

1

XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer : a multicenter, open-label, randomized, controlled, phase 3 trial

enthalten in: Signal transduction and targeted therapy | 2024

von Pan, Q. | Zhao, J. | Liu, L. | +27

2

Neoadjuvant docetaxel, oxaliplatin plus capecitabine versus oxaliplatin plus capecitabine for patients with locally advanced gastric adenocarcinoma : long-term results of a phase III randomized controlled trial

enthalten in: International journal of surgery (London, England) | 2023

von Tian, Y. | Yang, P. | Guo, H. | +14

3

Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE) : an open-label, superiority and non-inferiority, phase 3 randomised controlled trial

enthalten in: The Lancet. Oncology | 2021

von Zhang, X. | Liang, H. | Li, Z. | +43

ErratumIn: Lancet Oncol. 2021 Aug;22(8):e347. - PMID 34339653

4

The efficacy and safety of neoadjuvant chemotherapy on patients with advanced gastric cancer : A multicenter randomized clinical trial

enthalten in: Cancer medicine | 2020

von Zhao, Q. | Lian, C. | Huo, Z. | +12

5

Short-term curative effect of S-1 plus oxaliplatin as perioperative chemotherapy for locally advanced gastric cancer : a prospective comparison study

enthalten in: Die Pharmazie | 2017

von Zhao, Q. | Li, Y. | Huang, J. | +9

1
[1]